What top game-changing therapies will rock 2019 and deliver long-lasting consequences? Managed Healthcare Executive asked 7 industry leaders; Andrew Cournoyer, Precision for Value Vice President, Director, Payer Access Solutions, shares his vote. To read the full article, click here

Strengthens Precision’s Position as Leading Partner to Pharmaceutical and Life Sciences Companies at All Life Cycle Stages Bethesda, MD – December 17, 2018 – Precision Medicine Group, LLC. (Precision) today announced it has acquired Stern Investor Relations, Inc. (Stern IR), a leading investor relations firm for entrepreneurial biotechnology and healthcare […]

  Precision’s Senior VP, Darren Davis interviews with GenomeWeb to discuss the recent acquisition and merging of ApoCell with Precision for Medicine.